TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+13.63%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.76B
AUM Growth
+$122M
(+4.6%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-6.75%
Top 10 Holdings %
Top 10 Hldgs %
38.62%
Holding
217
New
37
Increased
33
Reduced
47
Closed
5
Top Buys
| 1 |
Zoetis
ZTS
|
$17.5M |
| 2 |
Johnson & Johnson
JNJ
|
$14.4M |
| 3 |
Elevance Health
ELV
|
$8.36M |
| 4 |
Novo Nordisk
NVO
|
$7.83M |
| 5 |
Thermo Fisher Scientific
TMO
|
$6.76M |
Top Sells
| 1 |
Merck
MRK
|
$45.3M |
| 2 |
Pfizer
PFE
|
$44.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$33.4M |
| 4 |
UnitedHealth
UNH
|
$21.5M |
| 5 |
Eli Lilly
LLY
|
$18.6M |
Sector Composition
| 1 | Healthcare | 93.74% |
| 2 | Real Estate | 2.75% |
| 3 | Financials | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLLS
76
Cellectis
CLLS
$264M
| $7.87M | 0.29% |
278,988
-38,962
| -12% | -$1.1M |
|
|
WMGI
77
DELISTED
Wright Medical Group Inc
WMGI
| $7.74M | 0.28% |
266,781
| – | – |
|
|
GWPH
78
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $7.53M | 0.27% |
43,598
-27,899
| -39% | -$4.82M |
|
79
Alkermes
ALKS
$4.77B
| $7.26M | 0.26% |
171,042
| – | – |
|
80
Medical Properties Trust
MPW
$2.67B
| $7.12M | 0.26% |
477,409
-381,177
| -44% | -$5.68M |
|
81
Smith & Nephew
SNN
$16.4B
| $6.88M | 0.25% |
185,478
+141,330
| +320% | +$5.24M |
|
82
ResMed
RMD
$40.1B
| $6.76M | 0.25% |
58,630
| – | – |
|
|
DOC
83
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $6.59M | 0.24% |
391,016
| – | – |
|
|
SHPG
84
DELISTED
Shire pic
SHPG
| $6.57M | 0.24% |
36,216
| – | – |
|
85
Ultragenyx Pharmaceutical
RARE
$3.01B
| $5.88M | 0.21% |
76,958
| – | – |
|
|
ARRY
86
DELISTED
Array Biopharma Inc
ARRY
| $5.54M | 0.2% |
364,166
+108,110
| +42% | +$1.64M |
|
87
Ventas
VTR
$30.8B
| $5.36M | 0.19% |
98,496
| – | – |
|
88
United Therapeutics
UTHR
$17.2B
| $5.28M | 0.19% |
41,261
| – | – |
|
|
EPZM
89
DELISTED
Epizyme, Inc
EPZM
| $5.14M | 0.19% |
485,325
| – | – |
|
|
ESRX
90
DELISTED
Express Scripts Holding Company
ESRX
| $5.06M | 0.18% |
53,250
-53,250
| -50% | -$5.06M |
|
|
GBT
91
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.03M | 0.18% |
132,270
+72,880
| +123% | +$2.77M |
|
|
MDCO
92
DELISTED
Medicines Co
MDCO
| $4.96M | 0.18% |
165,841
-72,900
| -31% | -$2.18M |
|
93
Bausch Health
BHC
$2.67B
| $4.93M | 0.18% |
192,000
| – | – |
|
|
ADAP
94
Adaptimmune Therapeutics
ADAP
$13.5M
| $4.77M | 0.17% |
351,618
-503,850
| -59% | -$6.83M |
|
95
Tenet Healthcare
THC
$17B
| $4.68M | 0.17% |
164,500
| – | – |
|
96
Ascendis Pharma
ASND
$12B
| $4.66M | 0.17% |
65,714
+21,800
| +50% | +$1.54M |
|
97
AnaptysBio
ANAB
$590M
| $4.58M | 0.17% |
+45,910
| New | +$4.58M |
|
98
Align Technology
ALGN
$9.76B
| $4.4M | 0.16% |
+11,244
| New | +$4.4M |
|
|
ARNA
99
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.32M | 0.16% |
93,767
| – | – |
|
100
Ionis Pharmaceuticals
IONS
$9.46B
| $4.27M | 0.16% |
82,838
| – | – |
|